GRoup A StrePtococcus
NCT01558804 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 180
Last updated 2026-02-18
Summary
The purpose of the research is to help understand why some children become carriers of strep and whether children who are carriers need to be treated with antibiotics.
Conditions
- Streptococcal Pharyngitis
Interventions
- OTHER
-
Identifying group A strep carriers
At study entry, at 14 days, and if follow up is positive, again in 14-21 days: Standard culture for GAS and analysis of mRNA.
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH -
University of Wisconsin, Madison
lead OTHER
Principal Investigators
-
Gregory DeMuri, MD · University of Wisconsin, Madison
Eligibility
- Min Age
- 5 Years
- Max Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-05-09
- Primary Completion
- 2028-06-30
- Completion
- 2028-06-30
Countries
- United States
Study Locations
More Related Trials
-
Pharyngeal Carriage Rates and Genetic Typing of Group A Streptococcus and Streptococcus Pneumonia Among Israeli Military Basic Trainees
NCT00808821 ·Status: COMPLETED
-
Streptococcal Infections in Fiji - Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in Fiji
NCT00436891 ·Status: COMPLETED
-
Human Immunity Against Staphylococcus Aureus Skin Infection
NCT02262819 ·Status: COMPLETED ·Phase: PHASE1
-
Colonization, Infection, and Molecular Typing of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Children.
NCT00254527 ·Status: COMPLETED
-
Preview Rapid Strep A Test Method Comparison Study
NCT03907449 ·Status: SUSPENDED
-
Bacterial Microbiota In The Tonsils Of Children
NCT01270243 ·Status: COMPLETED
-
Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Participants With Acute Pharyngitis
NCT03693495 ·Status: WITHDRAWN ·Phase: NA
-
Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Patients With Acute Pharyngitis.
NCT03171350 ·Status: COMPLETED ·Phase: NA
-
Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA
NCT01640886 ·Status: TERMINATED
-
Mol Epi GrAS in Nicaragua
NCT00170521 ·Status: TERMINATED
-
Strep A FIA Field Study, Sofia
NCT02153008 ·Status: COMPLETED
-
The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)
NCT00822276 ·Status: COMPLETED
-
Community-Assoc. S. Aureus Colonization and Recurrent Infection in Pts With Uncomplicated S. Aureus Skin Abscesses
NCT02690415 ·Status: COMPLETED
-
Invasive Disease Caused by Group A Streptococcus (GAS) (DICAR)
NCT03507101 ·Status: UNKNOWN
-
Virulence Determinants in S Aureus Bacteremia
NCT00319826 ·Status: COMPLETED
-
Efficacy Study of Vitamin D Supplementation to Meticillin Resistant Staphylococcus Aureus (MRSA) Carriers
NCT02178488 ·Status: COMPLETED ·Phase: PHASE2
-
SPOTFIRE Sore Throat (ST) Study
NCT06713642 ·Status: COMPLETED ·Phase: NA
-
Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons
NCT00631566 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant
NCT05695196 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections
NCT00156377 ·Status: COMPLETED ·Phase: PHASE4
-
Relationship of Staphylococcal Colonization to Infection
NCT00766259 ·Status: WITHDRAWN
-
Azithromycin for Meningococcal Carriage
NCT06618534 ·Status: RECRUITING ·Phase: PHASE2
-
Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia
NCT00622882 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of a Diagnostic Device for Detection of Nasal Staphylococcus Aureus
NCT00406549 ·Status: COMPLETED
-
Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment
NCT06805994 ·Status: RECRUITING ·Phase: PHASE1